Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Automated Cell Counter Market Growth From $6.12 Billion In 2026 To $7.68 Billion By 2030 At A CAGR Of 5.8%
The automated cell counter market has experienced strong growth in recent years. Its valuation is set to increase from $5.75 billion in 2025 to $6.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.6%. The expansion observed historically stems from factors such as growing reliance on manual cell counting limitations, rising clinical diagnostic testing volumes, increased funding for life science research, expansion of pharmaceutical quality control processes, and the demand for accurate and repeatable lab results.
The automated cell counter market is projected for substantial expansion over the next few years, with its size expected to reach $7.68 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.8%. This anticipated growth throughout the forecast period stems from factors such as increased research in personalized medicine, a rise in automation within clinical laboratories, the growing adoption of point-of-care diagnostics, advancements in cell-based assays, and the expansion of biotech research facilities. Significant trends influencing the market during this time include the broader utilization of automated cell counters in clinical diagnostics, an escalating demand for high-throughput cell analysis in research environments, a rising preference for optical-based automated cell counting systems, the wider application of automated cell counters in biopharmaceutical research and development, and their increasing integration into routine laboratory workflows.
Get A Free Sample Report With In-Depth Market Insights:
Automated Cell Counter Market Demand Drivers: What’s Powering Industry Growth?
The increasing acceptance of personalized medicine is projected to propel the expansion of the automated cell counter market going forward. Personalized medicine involves customizing medical care to each patient’s specific traits, frequently based on genetic, environmental, and lifestyle elements. The applications of personalized medicine are increasing due to advancements in genetic research and technology, facilitating more accurate and effective treatments tailored to individual patients’ distinct genetic profiles and health data. Automated cell counting finds application in personalized medicine to quickly and precisely analyze patient-specific cell populations, thus assisting in the customization of treatments based on individual cellular profiles. For instance, in February 2024, as per the Personalized Medicine Coalition (PMC), a US-based hospital and healthcare organization, the FDA approved 16 new personalized treatments for rare disease patients, a substantial increase from the 6 approved in 2022. Consequently, the rising adoption of personalized medicine will drive the growth of the automated cell counter market.
Automated Cell Counter Market Segment Landscape And Growth Outlook
The automated cell counter market covered in this report is segmented –
1) By Product: Consumable Accessories, Instruments
2) By Application: Blood Analysis, Urine Analysis, Microbial Cell Count, Cell Line Viability, Other Applications
3) By End User: Pharmaceuticals And Biotechnology Companies, Hospitals, Diagnostics Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Consumable Accessories: Cell Counting Reagents, Cell Counting Slides, Sample Tubes
2) By Instruments: Hemocytometers, Flow Cytometers, Automated Cell Counters (Optical Or Impedance-Based)
Automated Cell Counter Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading firms within the automated cell counter market are prioritizing the incorporation of intelligent algorithms and machine learning, exemplified by AI automated cell culture systems, to streamline and automate the processes of cell development and expansion in biological studies and biomanufacturing. An AI-automated cell culture system is a technology that leverages artificial intelligence for the independent monitoring, management, and optimization of cell proliferation and upkeep in laboratory environments. As an illustration, in October 2023, Molecular Devices LLC, an analytical systems supplier based in the U.S., launched the CellXpress.AI automated cell culture system. This solution is an all-encompassing, machine learning-driven offering designed to automate demanding feeding and passaging schedules through an integrated incubator, liquid handler, and imager, thereby affording scientists increased time and independence in their lab work. The core unit of this system integrates advanced technology intended for seamless oversight of the complete cell journey. It features sophisticated machine learning-powered software that facilitates the navigation and supervision of intricate cell culture processes, complete with built-in protocols for generating both two-dimensional and three-dimensional models.
Automated Cell Counter Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the automated cell counter market are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories Inc., HORIBA Ltd, Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation, Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc, Sony Biotechnology Inc., Countstar Inc., Aligned Genetics Inc.
View The Full Automated Cell Counter Market Report:
Automated Cell Counter Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the automated cell counter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell counter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
